Blue Sail Medical Co.,Ltd.

Shenzhen Stock Exchange 002382.SZ

Blue Sail Medical Co.,Ltd. Price to Sales Ratio (P/S) on January 27, 2025: 0.95

Blue Sail Medical Co.,Ltd. Price to Sales Ratio (P/S) is 0.95 on January 27, 2025, a -17.84% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Blue Sail Medical Co.,Ltd. 52-week high Price to Sales Ratio (P/S) is 1.18 on March 21, 2024, which is 24.11% above the current Price to Sales Ratio (P/S).
  • Blue Sail Medical Co.,Ltd. 52-week low Price to Sales Ratio (P/S) is 0.83 on July 24, 2024, which is -12.80% below the current Price to Sales Ratio (P/S).
  • Blue Sail Medical Co.,Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.01.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 002382.SZ

Blue Sail Medical Co.,Ltd.

CEO Mr. Shuqiao Zhong
IPO Date April 2, 2010
Location China
Headquarters 48 Yinuo Road
Employees 8,094
Sector Health Care
Industries
Description

Blue Sail Medical Co.,Ltd. manufactures and sells health protection gloves in China and internationally. The company offers disposable medical, latex, nitrile, PVC, TPE, and household gloves that are used for medical inspection and protection, food processing, electronics industry, etc. It is also involved in the research, development, production, and sales of cardiac stents and interventional cardiac surgery related equipment products. The company was formerly known as Shandong Blue Sail Plastic & Rubber Co., Ltd. and changed its name to Blue Sail Medical Co.,Ltd. in July 2014. Blue Sail Medical Co.,Ltd. was founded in 2002 and is based in Zibo, China.

Similar companies

300677.SZ

Intco Medical Technology Co., Ltd.

USD 3.75

NA

002030.SZ

Daan Gene Co., Ltd.

USD 0.73

NA

002223.SZ

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

USD 4.94

NA

002294.SZ

Shenzhen Salubris Pharmaceuticals Co., Ltd.

USD 4.11

NA

StockViz Staff

February 1, 2025

Any question? Send us an email